Vertex Pharmaceuticals Incorporated(NASDAQ:VRTX) 
Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regul...
Website: http://www.vrtx.com
Founded: 1989
Full Time Employees: 3,000
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 484.35
H 499.07
L 473.68
C 474.62
V 2,883,985
10EMA 474.62
20EMA 474.62
60EMA 474.62
120EMA 474.62
250EMA 474.62